RKT — Reckitt Benckiser Share Price
Last trade - 00:00- £32.64bn
- £41.96bn
- £14.21bn
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 14.63 | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | -0.75% | ||
| Dividend Yield (f) | 4.52% | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 5.76 | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | 22.01 | ||
| Price to Sales | 2.39 | ||
| EV to EBITDA | 9.29 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 23.92% | ||
| Return on Equity | 48.22% | ||
| Operating Margin | 28.49% | ||
Financial Summary
| Year End 31st Dec | Unit | 2021 | 2022 | 2023 | 2024 | 2025 | 2026E | 2027E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | £m | 13,234 | 14,453 | 14,607 | 14,169 | 14,205 | 12,887.2 | 13,358.75 | 0.3% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +63.37 | -29.41 | -15.1 | +0.26 | +23.45 | -14.18 | +8.02 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Reckitt Benckiser Group PLC (Reckitt) is a United Kingdom-based global consumer brands company. The Company's operating segments comprise Core Emerging Markets, Core Europe, Core North America, Essential Home and Mead Johnson Nutrition. Its self-care products include Strepsils, Mucinex, Gaviscon and Nurofen and provide over-the-counter treatments. Its Lysol, Dettol and Harpic protect against the spread of germs and drive adoption of hygienic habits. Its household care products include Finish and Vanish, which are cleaning solutions. Its intimate wellness products include Durex and Veet. Its brand Strepsils is a sore throat medicine. Gaviscon is a heartburn and indigestion relief provider. Mead Johnson Nutrition (MJN) provides infant and pediatric nutrition. Its subsidiaries include Mead Johnson Nutrition (Thailand) Ltd, Access VC Limited, Durex Limited, Reckitt Benckiser Healthcare Australia Pty Limited, and others.
Directors
- Christopher Sinclair NEC
- Laxman Narasimhan CEO
- Jeff Carr CFO
- Kris Licht CEX
- Aditya Sehgal CEX
- Ranjay Radhakrishnan CHO
- Filippo Catalano CIO
- Rupert Bondy GCN
- Volker Kuhn OTH
- Angela Naef OTH
- Sami Naffakh OTH
- Miguel Veiga-Pestana OTH
- Olivier Bohuon NID (62)
- Andrew Bonfield NID (57)
- Margherita Della Valle NID
- Nicandro Durante NID (64)
- Mary Harris NID (55)
- Mehmood Khan NID
- Pamela Kirby NID (68)
- Sara Mathew NID
- Elane Stock NID (56)
- Last Annual
- December 31st, 2025
- Last Interim
- June 30th, 2026
- Incorporated
- June 6th, 2007
- Public Since
- October 23rd, 2007
- No. of Shareholders
- 11,622
- No. of Employees
- 36,200
- Sector
- Personal & Household Products & Services
- Industry
- Consumer Defensives
- Exchange
- London Stock Exchange
- Shares in Issue
- 634,861,071
- Address
- 103-105 Bath Road, Berkshire, SLOUGH, SL1 3UH
- Web
- https://www.reckitt.com/
- Phone
- +44 1753217800
- Contact
- Nick Ashworth
- Auditors
- KPMG LLP
Latest News for RKT
Upcoming Events for RKT
Q3 2026 Reckitt Benckiser Group PLC Trading Statement Release
Reckitt Benckiser Group PLC Focus On: North America
Similar to RKT
Asia Strategic Holdings
London Stock Exchange
DSW Capital
London Stock Exchange
Fairview International
London Stock Exchange
Malvern International
London Stock Exchange
McBride
London Stock Exchange
FAQ
As of Today at 22:55 UTC, shares in Reckitt Benckiser are trading at 5,142.00p. This share price information is delayed by 15 minutes.
Shares in Reckitt Benckiser last closed at 5,142.00p and the price had moved by -8.84% over the past 365 days. In terms of relative price strength the Reckitt Benckiser share price has underperformed the FTSE All Share Index by -21.08% over the past year.
The overall consensus recommendation for Reckitt Benckiser is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreThe Reckitt Benckiser dividend yield is 4.21% based on the trailing twelve month period.
Last year, Reckitt Benckiser paid a total dividend of £2.16, and it currently has a trailing dividend yield of 4.21%.Looking ahead, the next dividend pay date is 2026-09-18.
We do not have data on when Reckitt Benckiser is to next pay dividends. The historic dividend yield on Reckitt Benckiser shares is currently 4.21%.
To buy shares in Reckitt Benckiser you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of 5,142.00p, shares in Reckitt Benckiser had a market capitalisation of £32.64bn.
Here are the trading details for Reckitt Benckiser:
- Country of listing: United Kingdom
- Exchange: LSE
- Ticker Symbol: RKT
Based on an overall assessment of its quality, value and momentum Reckitt Benckiser is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Reckitt Benckiser is 6,227.23p. That is 21.11% above the last closing price of 5,142.00p.
Analysts covering Reckitt Benckiser currently have a consensus Earnings Per Share (EPS) forecast of £3.34 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Reckitt Benckiser. Over the past six months, its share price has underperformed the FTSE All Share Index by -21.15%.
As of the last closing price of 5,142.00p, shares in Reckitt Benckiser were trading -5.16% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Reckitt Benckiser PE ratio based on its reported earnings over the past 12 months is 14.63. The shares last closed at 5,142.00p.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Reckitt Benckiser's management team is headed by:
- Christopher Sinclair - NEC
- Laxman Narasimhan - CEO
- Jeff Carr - CFO
- Kris Licht - CEX
- Aditya Sehgal - CEX
- Ranjay Radhakrishnan - CHO
- Filippo Catalano - CIO
- Rupert Bondy - GCN
- Volker Kuhn - OTH
- Angela Naef - OTH
- Sami Naffakh - OTH
- Miguel Veiga-Pestana - OTH
- Olivier Bohuon - NID
- Andrew Bonfield - NID
- Margherita Della Valle - NID
- Nicandro Durante - NID
- Mary Harris - NID
- Mehmood Khan - NID
- Pamela Kirby - NID
- Sara Mathew - NID
- Elane Stock - NID